UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047959
Receipt number R000054649
Scientific Title A retrospective exploratory integrative analysis of the efficacy of postoperative adjuvant chemotherapy for Stage II and III rectal cancer by stage of progression.
Date of disclosure of the study information 2022/06/06
Last modified on 2022/06/06 11:21:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A retrospective exploratory integrative analysis of the efficacy of postoperative adjuvant chemotherapy for Stage II and III rectal cancer by stage of progression.

Acronym

A retrospective exploratory integrative analysis of the efficacy of postoperative adjuvant chemotherapy for Stage II and III rectal cancer by stage of progression.

Scientific Title

A retrospective exploratory integrative analysis of the efficacy of postoperative adjuvant chemotherapy for Stage II and III rectal cancer by stage of progression.

Scientific Title:Acronym

A retrospective exploratory integrative analysis of the efficacy of postoperative adjuvant chemotherapy for Stage II and III rectal cancer by stage of progression.

Region

Japan


Condition

Condition

Rectal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Postoperative adjuvant chemotherapy for rectal cancer is similar to that for colorectal cancer, but there are very few reports on the effectiveness of postoperative adjuvant chemotherapy for rectal cancer alone. Currently, it is difficult to have a control group for surgery alone in clinical trials of adjuvant chemotherapy. This time, we will integrate four clinical trials including rectal cancer cases of the JFMC data base, utilized the surgery alone group as historical control data, adjusted the background bias using the propensity score, and we will examine the efficacy of postoperative adjuvant chemotherapy for rectal cancer at different stages of progression.

Basic objectives2

Others

Basic objectives -Others

We will integrate four clinical trials including rectal cancer cases of the JFMC data base, utilized the surgery alone group as historical control data, adjusted the background bias using the propensity score, and we will examine the efficacy of postoperative adjuvant chemotherapy for rectal cancer at different stages of progression.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Relapse-free survival

Key secondary outcomes

Overall survival


Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Of the 4 studies (No.7, 15, 35, 38)conducted by JFMC in the past, registered cases diagnosed with rectal cancer were included in the analysis.

Key exclusion criteria

-

Target sample size

3677


Research contact person

Name of lead principal investigator

1st name Takaki
Middle name
Last name Yoshikawa

Organization

Japanese Foundation for Multidisciplinary Treatment of Cancer

Division name

Database Project Support Committee

Zip code

136-0071

Address

Tani Building 3F, 1-28-6 Kameido, Koto-ku, Tokyo

TEL

0356277594

Email

jfmc-dc@jfmc.or.jp


Public contact

Name of contact person

1st name Yukari/Masaru
Middle name
Last name Kawamura/Mutoh

Organization

Japanese Foundation for Multidisciplinary Treatment of Cancer

Division name

Data Management Section/Statistical Analysis Section

Zip code

136-0071

Address

Tani Building 3F, 1-28-6 Kameido, Koto-ku, Tokyo

TEL

0356277594

Homepage URL


Email

jfmc-dc@jfmc.or.jp


Sponsor or person

Institute

Japanese Foundation for Multidisciplinary Treatment of Cancer

Institute

Department

Personal name



Funding Source

Organization

Japanese Foundation for Multidisciplinary Treatment of Cancer

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Epidemiological and Clinical research Information Network (ECRIN)

Address

21-7 Shogoin Sannocho Sakyo-ku, Kyoto-shi, Kyoto-fu 606-8392

Tel

075-762-1200

Email

naomi.iwahori@ecrin.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 06 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2022 Year 03 Month 25 Day

Date of IRB

2022 Year 03 Month 25 Day

Anticipated trial start date

2022 Year 09 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Relapse-free survival
Overall survival


Management information

Registered date

2022 Year 06 Month 06 Day

Last modified on

2022 Year 06 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054649